Detalhe da pesquisa
1.
A novel germline hyperactivating JAK2 mutation L604F.
Ann Hematol
; 102(10): 2725-2734, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37639050
2.
Integrin expression and adhesivity to fibronectin in primary acute myeloid leukemia cells: Impact of NPM1 and FLT3 mutations.
Eur J Haematol
; 105(5): 578-587, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668024
3.
Functionalized aromatic esters of the Amaryllidaceae alkaloid haemanthamine and their in vitro and in silico biological activity connected to Alzheimer's disease.
Bioorg Chem
; 100: 103928, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32450384
4.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
; 390(10114): 2790-2802, 2017 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061295
5.
Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma.
Hematol Oncol
; 36(1): 110-115, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29083050
6.
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
Lancet Oncol
; 18(4): 454-463, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28236583
7.
Sentence comprehension in Slovak-speaking patients with Alzheimer's disease.
Int J Lang Commun Disord
; 52(4): 456-468, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28000389
8.
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Lancet
; 385(9976): 1418-27, 2015 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25539730
9.
Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?
Acta Haematol
; 134(3): 187-92, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26021284
10.
Sodium/calcium exchanger is upregulated by sulfide signaling, forms complex with the ß1 and ß3 but not ß2 adrenergic receptors, and induces apoptosis.
Pflugers Arch
; 466(7): 1329-42, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114174
11.
Triptolide induces apoptosis through the SERCA 3 upregulation in PC12 cells.
Gen Physiol Biophys
; 33(1): 137-44, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24448368
12.
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
Lancet
; 379(9828): 1791-9, 2012 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22480758
13.
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Blood
; 118(24): 6292-8, 2011 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21917759
14.
Mitochondrial chloride channels: electrophysiological characterization and pH induction of channel pore dilation.
Eur Biophys J
; 42(9): 709-20, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23903554
15.
Language impairment in Parkinson's disease: fMRI study of sentence reading comprehension.
Front Aging Neurosci
; 15: 1117473, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967818
16.
Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia.
Eur J Haematol
; 88(2): 128-35, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21967546
17.
NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia.
Oncoimmunology
; 11(1): 2073050, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35558161
18.
Unusually long survival of a 67-year-old patient with near-tetraploid acute myeloid leukemia m0 without erythroblastic and megakaryocytic dysplasia.
Acta Haematol
; 126(3): 129-34, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21701158
19.
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
Lancet Haematol
; 8(4): e278-e288, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33770483
20.
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
Lancet Haematol
; 8(6): e398-e409, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048679